Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Hangzhou Weiyuan Biotechnology

Request full access

Synthetic biology for chiral compounds and functional materials

Hangzhou, ChinaFounded 2023Biotech & Life Sciences

About Hangzhou Weiyuan Biotechnology

Hangzhou Weiyuan Biotechnology Co., Ltd. is a synthetic biology company founded in 2023. The company's technical foundation is built on the directed evolution of enzymes, multi-enzyme cascades, and the integration of enzymatic reactions with chemical synthesis. It leverages intelligent enzyme evolution and high-throughput strain screening as its core technology engine.

The founder and CEO, Wu Yan, graduated from Zhejiang University with a major in Bioengineering and has over two decades of experience in biopharmaceutical R&D and industrialization. The co-founder and CTO, Luo Zhibo, holds a PhD in Engineering from Tsinghua University and has a background in synthetic biology and chemical engineering research.

Weiyuan Biotechnology is focused on building a comprehensive enzyme library to produce chiral compounds, natural product extracts, and functional raw materials. The firm provides high-performance biological elements for the biomanufacturing industry, which are applied to the efficient production of chiral compounds, the enzymatic hydrolysis of active natural products, and the construction of cell-free multi-enzyme cascade systems. Its business serves other companies in the biotechnology sector. The company operates on a venture capital-backed, privately held ownership model and has completed Seed and Early Stage VC funding rounds.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
20.3/100
Industry
Health, Chemicals
Sub-industry
BioTechnology
Sector
Biotechnology, Synthetic Biology, Biotech and Pharma, precision fermentation, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SEED✓Equity / VC Aug 2025 $14M $55M Roton Capital · Zhejiang Dajing Venture Capital · Dalton Venture · True Stone Capital ↗
SEED✓Equity / VC Jun 2024 $2.8M $11M Undisclosed ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Hangzhou Weiyuan Biotechnology website traffic

Latest recorded traffic for Hangzhou Weiyuan Biotechnology is 1.1K monthly website visits, up 103.7% over the last three months.

Latest monthly visits1.1K 3-month web change+103.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Hangzhou Weiyuan Biotechnology in the Hangzhou ecosystem

Live from Dealroom

The Hangzhou Weiyuan Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

  • Roton Capital
  • Zhejiang Dajing Venture Capital
  • Dalton Venture
  • True Stone Capital
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Hangzhou HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Hangzhou Weiyuan Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Hangzhou Weiyuan Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.